TELOTelo GenomicsTELO info
$0.08info4.35%24h
Global rank32205
Market cap$5.02M
Change 7d4.35%
YTD Performance-41.46%
SP500 benchmarkUnderperform
P/E-1.67
P/S0
Revenue$0
Earnings-$1.96M
Dividend yield-
Main Sector
Healthcare

Telo Genomics (TELO) Stock Overview

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.

TELO Stock Information

Symbol
TELO
Address
MaRS CentreToronto, ON M5G 1L7Canada
Founded
-
Trading hours
-
Website
https://www.telodx.com
Country
🇨🇦 Canada
Phone Number
416-673-8487

Telo Genomics (TELO) Price Chart

-
Value:-

Telo Genomics Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.08350440137782263
N/A
Market Cap
$5.02M
N/A
Shares Outstanding
60.15M
2.54%
Employees
0
N/A
Shareholder Equity
2.61M
0.37%
Valuation
2023
Change
P/E Ratio
-1.67
N/A
P/B Ratio
1.92
N/A
Growth
2023
Change
Return on Equity
-0.7513
N/A
Earnings
2023
Change
Revenue
$0
N/A
Earnings
-$1.96M
N/A
EPS
-0.05
N/A
Earnings Yield
-0.5988
N/A
Financial Strength
2023
Change
Total Assets
$2.04M
N/A
Cash on Hand
$1.86M
N/A
Debt to Equity
0.0833
35.49%
Current Ratio
$10.14
-30.83%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org